Publication date: Available online 31 October 2026 Source: Clinical Gastroenterology and Hepatology Author(s): Guillaume Le Cosquer, Mukesh Kumar Ranjan, Bharati Kochar, Adam S. Faye, Siddharth Singh, Ashwin N. Ananthakrishnan
Safety of Janus kinase inhibitors, ustekinumab, and anti-interleukin-23 in older patients with immune-mediated diseases. // Clinical Gastroenterology and Hepatology. – URL: https://www.sciencedirect.com/science/article/pii/S1542356526008190?dgcid=rss_sd_all
Safety of Janus kinase inhibitors, ustekinumab, and anti-interleukin-23 in older patients with immune-mediated diseases. Clinical Gastroenterology and Hepatology. https://www.sciencedirect.com/science/article/pii/S1542356526008190?dgcid=rss_sd_all
“Safety of Janus kinase inhibitors, ustekinumab, and anti-interleukin-23 in older patients with immune-mediated diseases.” Clinical Gastroenterology and Hepatology.
@article{article99946,
title = {Safety of Janus kinase inhibitors, ustekinumab, and anti-interleukin-23 in older patients with immune-mediated diseases},
journal = {Clinical Gastroenterology and Hepatology},
url = {https://www.sciencedirect.com/science/article/pii/S1542356526008190?dgcid=rss_sd_all}
}